- Altered cerebellar and cortical structures in autistic children are related and may give rise to changes in functional connectivity with maturation. Spectrum has previously reported on cerebellum size and neurodevelopmental conditions. Molecular Psychiatry
- Mice with diminished expression of the autism-linked gene SYNGAP1 in forebrain GABAergic interneurons show altered neural activity and social behaviors. Journal of Neuroscience
- People with autism or schizophrenia have altered AMPA glutamate receptor density, according to a brain imaging study. Molecular Psychiatry
Cerebellum structure; AMPA receptors; MAGEL2 gene
Here is a roundup of autism-related news and research spotted around the web for the week of 28 October.
By
Jill Adams
29 October 2024 | 1 min read

Amped up: The density of AMPA glutamate receptors is higher (red) in some brain areas in autistic people, and lower (blue) in others, compared with non-autistic people.
- Nearly all excitatory neurons in human cortical organoids are produced indirectly from intermediate progenitor cells. Cell Reports
- Autistic people’s brain regions show an altered maturation pattern, which appears to be tied to clinical traits. JAMA Psychiatry
- Mice missing the gene MAGEL2, a model of Prader-Willi syndrome, have heightened somatostatin activity in the lateral septum and altered sociability that can be mitigated by oxytocin and vasopressin. Cell Reports Medicine
tags:
Recommended reading
Genetic profiles separate early, late autism diagnoses
By
Natalia Mesa
27 November 2025 | 5 min read
SHANK3 deficiency and behavior in mice; and more
By
Jill Adams
25 November 2025 | 2 min read
Autism scientists push back on CDC’s inaccurate vaccine claims
By
The Transmitter
21 November 2025 | 6 min read
Explore more from The Transmitter
To persist, memories surf molecular waves from thalamus to cortex
By
Claudia López Lloreda
26 November 2025 | 4 min read
Sex hormone boosts female rats’ sensitivity to unexpected rewards
By
Angie Voyles Askham
26 November 2025 | 5 min read
Remembering Mark Hallett, leader in transcranial magnetic stimulation
By
David Dobbs
25 November 2025 | 7 min read
Cite this article: